Problems of choosing antimicrobial therapy in young children with community-acquired pneumonia
Z. A. Shangareeva,
R. M. Faizullina,
A. V. Sannikova,
A. F. Mananova,
O. L. Berezina,
O. V. Islamgulova,
L. V. Pererva,
A. V. Larina https://doi.org/10.21886/2219-8075-2025-16-1-74-80
Abstract
Objective: to analyze the prescribed antimicrobial therapy in young children with non-severe community-acquired pneumonia. Materials and methods: a sample of 219 young children with community-acquired pneumonia admitted to the pediatric department of the State Children's Clinical Hospital №17 in Ufa for the period from September 2022 to August 2023 was formed. Results: the clinical and anamnestic characteristics of children with community-acquired pneumonia are described. Analysis of antimicrobial therapy at the outpatient stage revealed in 51,24% of cases its compliance with clinical recommendations. There was a large share of parenteral drugs (73,97%) in the treatment of community-acquired pneumonia in a hospital setting. Preference was given to ceftriaxone (43,38%) due to the convenience of the method of administration. Inhibitor-protected aminopenicillins were prescribed half as often (23,29%). Conclusion: The authors believe that well-planned educational interventions will improve the effectiveness of antimicrobial therapy for community-acquired pneumonia in children.
About the Authors
Z. A. Shangareeva
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Ziliya A. Shangareeva, PhD, associate Professor of the Department of Faculty Pediatrics and Neonatology
Ufa
Competing Interests:
Authors declare no conflict of interest
R. M. Faizullina
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Reseda M. Faizullina, Dr. Sci. (Med.), Professor of the Department of Faculty Pediatrics and Neonatology
Ufa
Competing Interests:
Authors declare no conflict of interest
A. V. Sannikova
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Anna V. Sannikova, PhD, associate Professor of the Department of Faculty Pediatrics and Neonatology
Ufa
Competing Interests:
Authors declare no conflict of interest
A. F. Mananova
City Children's Clinical Hospital No. 17
Russian Federation
Competing Interests:
Russian Federation
Albina F. Mananova, head of the Pediatrics department
Ufa
Competing Interests:
Authors declare no conflict of interest
O. L. Berezina
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Olesya L. Berezina, 2-year resident, Department of Faculty Pediatrics and Neonatology
Ufa
Competing Interests:
Authors declare no conflict of interest
O. V. Islamgulova
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Olga V. Islamgulova, 2-year resident of the Department of Faculty Pediatrics and Neonatology
Ufa
Competing Interests:
Authors declare no conflict of interest
L. V. Pererva
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Lyudmila V. Pererva, 2-year resident, Department of Faculty Pediatrics and Neonatology
Ufa
Competing Interests:
Authors declare no conflict of interest
A. V. Larina
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Anna V. Larina, 1st year resident, Department of Faculty Pediatrics and Neonatology
Ufa
Competing Interests:
Authors declare no conflict of interest
References
1. Klinicheskie rekomendacii. M; 2022. (In Russ.).
2. Ivanchik N.V., Chagaryan A.N., Suxorukova M.V., Kozlov R.S., Dexnich A.V. et al. Antimicrobial resistance of clinical Streptococcus pyogenes isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017». Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):40-45. (In Russ.). https://doi.org/10.36488/cmac.2020.1.40-45
3. Fajzullina R.M., Shangareeva Z.A., Sannikova A.V., Muxametzyanov A.M., Zajcev S.V., et al. Community-acquired pneumonia in children of the first five years of life. Prakticheskaya pul`monologiya. 2019;(4):30-36. (In Russ.). eLIBRARY ID: 42699180 EDN: CFONYD
4. Zaytseva SV, Zaytseva OV. Current guidelines for the selection of an antibacterial drug in children with communityacquired pneumonia. Meditsinskiy sovet = Medical Council. 2022;(6):158-165. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-6-158-165
5. Kuzmenkov A.Yu., Vinogradova A.G., Trushin I.V., Edelstein M.V. Avramenko A.A., et al. AMRmap – antibiotic resistance surveillance system in Russia. Clinical Microbiology and Antimicrobial Chemotherapy. 2021;23(2):198-204. (In Russ.). https://doi.org/10.36488/cmac.2021.2.198-204
6. Strachunskij L.S., Kozlov S.N. Sovremennaya antimikrobnaya ximioterapiya. Rukovodstvo dlya vrachej. Moscow: Borges; 2002 (In Russ.).
7. Vinogradova A.G., Kuzmenkov A.Yu. Application of AMRmap: «from the general to the specific» approach by the example of Klebsiella pneumoniae. Clinical Microbiology and Antimicrobial Chemotherapy. 2019;21(2):181-186. (In Russ.). https://doi.org/10.36488/cmac.2019.2.181-186
8.
Review
For citations:
Shangareeva Z.A., Faizullina R.M., Sannikova A.V., Mananova A.F., Berezina O.L., Islamgulova O.V., Pererva L.V., Larina A.V. Problems of choosing antimicrobial therapy in young children with community-acquired pneumonia. Medical Herald of the South of Russia. 2025;16(1):74-80. (In Russ.) https://doi.org/10.21886/2219-8075-2025-16-1-74-80
Views:
146
Email this article 